Pro-proliferative FoxM1 is a target of p53-mediated repression

被引:126
|
作者
Barsotti, A. M. [1 ]
Prives, C. [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
p53; FoxM1; transcriptional repression; p21; Rb; G2; arrest; M1 TRANSCRIPTION FACTOR; P53; TUMOR-SUPPRESSOR; MOUSE-LIVER REGENERATION; CELL-CYCLE PROGRESSION; WILD-TYPE P53; DNA-DAMAGE; DOWN-REGULATION; C-MYC; FUNCTIONAL DOMAINS; INDUCED SENESCENCE;
D O I
10.1038/onc.2009.282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein acts as a transcription factor to modulate cellular responses to a wide variety of stresses. In this study we show that p53 is required for the downregulation of FoxM1, an essential transcription factor that regulates many G2/M-specific genes and is overexpressed in a multitude of solid tumors. After DNA damage, p53 facilitates the repression of FoxM1 mRNA, which is accompanied by a decrease in FoxM1 protein levels. In cells with reduced p53 expression, FoxM1 is upregulated after DNA damage. Nutlin, a small-molecule activator of p53, suppresses FoxM1 levels in two cell lines in which DNA damage facilitates only mild repression. Mechanistically, p53-mediated inhibition of FoxM1 is partially p21 and retinoblastoma (Rb) family dependent, although in some cases p21-independent repression of FoxM1 was also observed. The importance of FoxM1 to cell fate was indicated by the observation that G2/M arrest follows FoxM1 ablation. Finally, our results indicate a potential contribution of p53-mediated repression of FoxM1 for maintenance of a stable G2 arrest. Oncogene (2009) 28, 4295-4305; doi: 10.1038/onc.2009.282; published online 14 September 2009
引用
收藏
页码:4295 / 4305
页数:11
相关论文
共 50 条
  • [31] Mechanisms of p53-mediated apoptosis
    Bates, S
    Vousden, KH
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) : 28 - 37
  • [32] Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
    Wang, Zebin
    Zheng, Yu
    Park, Hyun Jung
    Li, Jing
    Carr, Janai R.
    Chen, Yi-ju
    Kiefer, Megan M.
    Kopanja, Dragana
    Bagchi, Srilata
    Tyner, Angela L.
    Raychaudhuri, Pradip
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05) : 759 - 767
  • [33] Mechanisms of p53-mediated apoptosis
    S. Bates
    K. H. Vousden
    Cellular and Molecular Life Sciences CMLS, 1999, 55 : 28 - 37
  • [34] Advances in inhibitors of potential tumor target FOXM1
    Han, Xiao-Yang
    Zhou, Zi-Ying
    Li, Si-Yan
    Xue, Si-Tu
    FUTURE MEDICINAL CHEMISTRY, 2023, 15 (10) : 809 - 812
  • [35] Mechanisms of p53-mediated apoptosis
    Ding, HF
    Fisher, DE
    CRITICAL REVIEWS IN ONCOGENESIS, 1998, 9 (01): : 83 - 98
  • [36] The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation
    Saifudeen, Z
    Du, H
    Dipp, S
    El-Dahr, SS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 15557 - 15562
  • [37] Is there potential to target FOXM1 for 'undruggable' lung cancers?
    Kalinichenko, Vladimir V.
    Kalin, Tanya V.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (07) : 865 - 867
  • [38] Investigation of FOXM1 as a Potential New Target for Melanoma
    Miyashita, Azusa
    Fukushima, Satoshi
    Nakahara, Satoshi
    Yamashita, Junji
    Tokuzumi, Aki
    Aoi, Jun
    Ichihara, Asako
    Kanemaru, Hisashi
    Jinnin, Masatoshi
    Ihn, Hironobu
    PLOS ONE, 2015, 10 (12):
  • [39] p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding
    Lee, KC
    Crowe, AJ
    Barton, MC
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (02) : 1279 - 1288
  • [40] Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response
    Jack, MT
    Woo, RA
    Hirao, A
    Cheung, A
    Mak, TW
    Lee, PWK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) : 9825 - 9829